BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 28.32%447.54M | 35.73%725.1M | 43.39%348.78M | 15.64%534.22M | 9.92%243.24M | 5.77%461.98M | 10.21%221.29M | 0.20%436.77M | --200.79M | 12.35%435.88M |
Operating income | 28.32%447.54M | 35.73%725.1M | 43.39%348.78M | 15.64%534.22M | 9.92%243.24M | 5.77%461.98M | 10.21%221.29M | 0.20%436.77M | 200.79M | 12.35%435.88M |
Cost of sales | -30.98%-359.47M | -40.80%-578.13M | -46.67%-274.45M | -15.42%-410.61M | -10.40%-187.12M | -3.21%-355.76M | -7.29%-169.49M | 0.79%-344.7M | ---157.97M | -9.57%-347.46M |
Operating expenses | -30.98%-359.47M | -40.80%-578.13M | -46.67%-274.45M | -15.42%-410.61M | -10.40%-187.12M | -3.21%-355.76M | -7.29%-169.49M | 0.79%-344.7M | -157.97M | -9.57%-347.46M |
Gross profit | 18.48%88.07M | 18.90%146.97M | 32.44%74.33M | 16.37%123.61M | 8.34%56.12M | 15.38%106.23M | 20.99%51.8M | 4.12%92.07M | 42.82M | 24.82%88.42M |
Selling expenses | 11.74%-1.58M | -11.27%-3.32M | -29.75%-1.79M | -7.93%-2.98M | -4.16%-1.38M | -14.61%-2.76M | -43.65%-1.32M | -28.60%-2.41M | ---921K | -10.24%-1.87M |
Administrative expenses | -0.23%-28.04M | -40.81%-49.93M | -132.27%-27.98M | -22.26%-35.46M | 35.98%-12.05M | 19.94%-29M | -9.82%-18.81M | -12.02%-36.23M | ---17.13M | -7.91%-32.34M |
Operating interest expense | ---- | ---- | ---- | ---- | -185.53%-4.3M | 83.93%-3.87M | 87.40%-1.51M | -3.60%-24.06M | ---11.96M | -58.98%-23.22M |
Special items of operating profit | -157.31%-6.27M | 49.37%24.92M | 343.35%10.93M | 86.08%16.69M | -26.98%2.47M | -74.29%8.97M | -77.45%3.38M | 28.42%34.88M | --14.98M | 14.38%27.16M |
Operating profit | -5.98%52.18M | 16.49%118.65M | 35.81%55.5M | 28.02%101.86M | 21.84%40.86M | 23.83%79.56M | 20.71%33.54M | 10.50%64.25M | 27.78M | 20.36%58.15M |
Financing cost | 13.46%-6.84M | -26.74%-15.18M | ---7.9M | ---11.98M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | ---- | 152.86%1.06M | ---- | 33.10%-2.01M | 39.01%-1.02M | ---3.01M | ---1.68M | ---- | ---- | ---- |
Share of profit from joint venture company | 97.67%-6K | ---- | ---258K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | -4.23%45.33M | 18.97%104.54M | 18.82%47.34M | 14.78%87.87M | 25.05%39.84M | 19.15%76.55M | 14.67%31.86M | 10.50%64.25M | 27.78M | 20.36%58.15M |
Tax | -1.32%-12.97M | -7.07%-24.41M | -23.86%-12.81M | -13.81%-22.8M | -29.40%-10.34M | -24.08%-20.04M | -14.83%-7.99M | -10.67%-16.15M | ---6.96M | -20.06%-14.59M |
After-tax profit from continuing operations | -6.29%32.36M | 23.14%80.12M | 17.05%34.53M | 15.12%65.07M | 23.59%29.5M | 17.49%56.52M | 14.62%23.87M | 10.44%48.1M | 20.83M | 20.46%43.55M |
Earning after tax | -6.29%32.36M | 23.14%80.12M | 17.05%34.53M | 15.12%65.07M | 23.59%29.5M | 17.49%56.52M | 14.62%23.87M | 10.44%48.1M | 20.83M | 20.46%43.55M |
Minority profit | -39.24%1.17M | 493.53%5.69M | 93.67%1.93M | -8.84%959K | 110.13%996K | 37.70%1.05M | -13.97%474K | -25.97%764K | --551K | 35.43%1.03M |
Profit attributable to shareholders | -4.34%31.19M | 16.10%74.43M | 14.37%32.6M | 15.58%64.11M | 21.84%28.51M | 17.17%55.47M | 15.39%23.4M | 11.33%47.34M | 20.28M | 20.14%42.52M |
Basic earnings per share | -3.13%0.31 | -2.63%0.74 | -15.79%0.32 | 2.70%0.76 | 22.58%0.38 | 7.25%0.74 | -6.06%0.31 | -44.35%0.69 | 0.33 | 20.39%1.24 |
Diluted earnings per share | -3.13%0.31 | -2.63%0.74 | -15.79%0.32 | 2.70%0.76 | 22.58%0.38 | 7.25%0.74 | -6.06%0.31 | -44.35%0.69 | 0.33 | 20.39%1.24 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.